Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Uterus (Corpus & Uterus, NOS) (Late Stage^), 2017-2021

All Races (includes Hispanic), Female, All Ages

Sorted by Rate

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 7.3 (7.2, 7.3) N/A 15,529 26.6
District of Columbia 6 10.6 (9.1, 12.2) 1 (1, 6) 39 33.2
Hawaii 3 10.0 (9.1, 11.0) 2 (1, 5) 95 30.1
New York 3 9.0 (8.8, 9.2) 3 (2, 5) 1,259 29.7
New Jersey 3 8.9 (8.6, 9.3) 4 (2, 6) 576 28.9
Connecticut 3 8.6 (8.1, 9.2) 5 (2, 10) 225 29.7
California 3 8.3 (8.2, 8.5) 6 (5, 9) 1,986 30.3
Illinois 3 8.2 (7.9, 8.5) 7 (5, 11) 699 27.3
Georgia 3 7.9 (7.6, 8.3) 8 (5, 15) 533 31.6
Pennsylvania 6 7.8 (7.6, 8.1) 9 (6, 16) 748 24.6
Maryland 6 7.7 (7.3, 8.1) 10 (6, 19) 330 28.2
Michigan 6 7.7 (7.4, 8.0) 11 (7, 18) 540 26.8
West Virginia 6 7.6 (6.9, 8.3) 12 (5, 31) 102 22.5
Florida 6 7.6 (7.4, 7.8) 13 (8, 18) 1,220 28.5
Ohio 6 7.5 (7.2, 7.7) 14 (9, 21) 610 24.6
Wisconsin 6 7.5 (7.1, 7.9) 15 (8, 24) 306 24.9
Alaska 6 7.3 (6.1, 8.7) 16 (3, 47) 29 25.7
New Mexico 3 7.2 (6.6, 7.9) 17 (7, 37) 101 29.5
Iowa 3 7.0 (6.5, 7.5) 19 (10, 37) 149 23.5
Washington 5 7.0 (6.6, 7.3) 20 (14, 34) 332 25.7
Texas 3 6.9 (6.8, 7.1) 21 (16, 30) 1,110 27.8
Delaware 6 6.9 (6.1, 7.9) 22 (6, 45) 53 24.2
Missouri 6 6.9 (6.5, 7.2) 23 (15, 36) 290 24.9
Kentucky 3 6.8 (6.4, 7.3) 24 (14, 37) 205 25.4
Puerto Rico 6 6.8 (6.3, 7.4) N/A 150 22.4
North Carolina 6 6.8 (6.5, 7.1) 25 (16, 35) 485 25.8
Louisiana 3 6.8 (6.4, 7.2) 26 (14, 38) 209 32.5
Nebraska 6 6.8 (6.1, 7.5) 27 (9, 44) 82 24.8
Minnesota 6 6.7 (6.3, 7.1) 28 (15, 39) 248 22.5
Utah 3 6.5 (6.0, 7.2) 29 (15, 45) 99 24.2
Virginia 6 6.5 (6.2, 6.8) 30 (21, 40) 370 25.3
Idaho 3 6.5 (5.8, 7.2) 31 (12, 47) 73 26.2
Oregon 6 6.5 (6.1, 6.9) 32 (17, 44) 184 21.4
Mississippi 6 6.5 (6.0, 7.0) 33 (16, 45) 128 27.2
Oklahoma 6 6.5 (6.0, 7.0) 34 (17, 44) 161 26.6
Vermont 6 6.4 (5.4, 7.5) 35 (8, 49) 33 21.1
Kansas 6 6.4 (5.9, 6.9) 36 (17, 46) 119 24.2
South Carolina 6 6.3 (5.9, 6.7) 37 (23, 46) 227 26.6
Arizona 6 6.1 (5.8, 6.4) 38 (29, 46) 283 25.9
Arkansas 6 6.0 (5.5, 6.5) 39 (26, 48) 122 24.4
Colorado 6 5.9 (5.6, 6.3) 40 (30, 48) 207 26.3
Tennessee 6 5.9 (5.6, 6.3) 41 (32, 47) 275 23.8
New Hampshire 6 5.9 (5.3, 6.7) 42 (20, 49) 62 20.3
Nevada 6 5.9 (5.4, 6.4) 43 (27, 48) 112 24.9
Rhode Island 6 5.7 (5.0, 6.5) 44 (22, 50) 46 20.9
Maine 6 5.6 (5.0, 6.3) 45 (28, 50) 61 18.3
Montana 6 5.6 (4.8, 6.5) 46 (24, 50) 43 22.1
North Dakota 6 5.5 (4.5, 6.6) 47 (19, 50) 24 21.2
Wyoming 6 5.3 (4.2, 6.5) 48 (18, 50) 19 22.7
South Dakota 6 4.9 (4.1, 5.8) 49 (37, 50) 29 19.5
Alabama 6 4.8 (4.5, 5.1) 50 (46, 50) 168 24.4
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2024 1:30 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top